Half Year 2021 Futura Medical PLC Earnings Call Transcript
Well, good morning, everybody. Welcome to Futura Medical's interim Results for 6 Months, 30th of June 2021 webcast. I'm delighted to say I'm being joined, and I being James Barder, the CEO; by Angela Hildreth, who is the Chief Operating Officer and Finance Director of the company; and also by Ken James, who is Executive Head of R&D.
Without further ado, can we please move to Slide 4. For those that don't know much about Futura, this is just a brief overview about the company. We are an AIM listed company, listed -- rather located in the Research Park in Guildford. And we describe ourselves as a virtual organization. We have 13 staff with low overheads, but we have a significant outsourced infrastructure with over 30 consultants, which we plug it in (inaudible) when we need to, to keep our costs down.
Our real core expertise, we loosely describe as DermaSys, and this is about applying skin (inaudible) to deliver novel topically, clinically proven treatments. We have a track record of developing clinically proven
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
